"The message is that there were problems with the integrity of the decision making process," but those problems "have solutions."

— Deputy FDA commissioner Joshua Sharfstein, MD, speaking at a special press conference on the application for Menaflex collagen made by ReGen Biologics (Franklin Lakes, New Jersey), which has been scrutinized for how it's FDA review was handled. "FDA: Menaflex stays for now, but process was badly warped."